Ultra Low Dose LNG IUS

Alternative Name: LNG Contraceptive IUS 12 (LCS12)

Description: A low-dose levonorgestrel contraceptive intrauterine system (LCS), LCS12 delivers 12 µg/24h and is effective for 3 years. It is under development by Bayer Healthcare.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Intrauterine

Duration Type: Long-acting

Duration: 3 years

Regimen:
  • Single insertion

Dose: 12 microg/24 h

Active Pharmaceutical Ingredient (API):
  • levonorgestrel

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: Bayer HealthCare

Project Phase: Limited Market Availability

Development Stage: Regulatory

Active Development: Yes

Status Details:
  • Phase III clinical trial completed in 2015.
  • In Nov. 2015, Bayer preregistered the product for contraception in the European Union.

Additional Information

References:

Vertical Tabs

Print